Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pinterest

European adoption of physician-only social networks growing

UK showed clear lead in use last year, according to Manhattan Research

- PMLiVE

Creation Healthcare claims social media monitoring first

New Creation Pinpoint service allows pharma to monitor public HCP conversations

- PMLiVE

PatientsLikeMe takes aim at one of world’s rarest diseases

Creates open registry and community for alkaptonuria patients

- PMLiVE

Olympic gold medalist becomes face of Asthma UK

Cyclist Laura Trott is supporting the charity’s Facebook page

Novartis building

Novartis parts with Eisai to go it alone with COPD drugs

Ends co-promotion agreement for Onbrez, Seebri and QVA149

- PMLiVE

Pharma social media update – Twitter

AbbVie's Twitter debut is the perfect opportunity for a Digital Handbook update

- PMLiVE

NICE set to approve Novartis eye drug Lucentis

Final draft guidance says treatment is cost-effective in diabetic macular oedema

Novartis building

Novartis’ Exjade gets EU approval for thalassaemia

First oral treatment for condition characterised by red blood cell problems and anaemia

- PMLiVE

Year-end FDA approvals for Novartis, GSK drugs

Agency gives go-ahead to Cushing’s disease treatment Signifor and raxibacumab for inhalational anthrax

- PMLiVE

Pharma’s 2012 in … social media

Blogs, Pinterest and Twitter all feature in the first part of my digital review

- PMLiVE

Boehringer talks More Health on new blog

Pharma company's US team looks to connect with 'social entrepreneurs'

- PMLiVE

Sanofi picks corporate voice for new blogging venture

Pharma company's US arm goes beyond discussing diabetes

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links